Jean-Michel Hannoun-Levi, MD, Antoine Lacassagne Cancer Center, Nice, France, discusses the rationale behind recommending second breast conserving surgery in patients with breast cancer with small recurrence early disease. Data specific treatment and novel inclusion criteria have demonstrated the benefits of second conservative treatment in certain patients. This interview took place at the 14th European Breast Cancer Conference (EBCC) in Milan, Italy.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.